Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antibody"" wg kryterium: Temat


Tytuł:
Structural Features of Antibody-Peptide Recognition.
Autorzy:
Lee JH; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, United States.
Yin R; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, United States.; University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD, United States.
Ofek G; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, United States.; University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD, United States.
Pierce BG; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, United States.; University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD, United States.; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Jul 07; Vol. 13, pp. 910367. Date of Electronic Publication: 2022 Jul 07 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Antigen-Antibody Complex*/chemistry
Vaccines*
Antigens ; Binding Sites, Antibody ; Epitopes/chemistry ; Models, Molecular ; Peptides/chemistry ; Protein Conformation
Czasopismo naukowe
Tytuł:
Fc-Mediated Functions of Porcine IgG Subclasses.
Autorzy:
Paudyal B; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Mwangi W; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Rijal P; Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Schwartz JC; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Noble A; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Shaw A; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Sealy JE; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Bonnet-Di Placido M; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Graham SP; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Townsend A; Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Hammond JA; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Tchilian E; Host Responses, The Pirbright Institute, Woking, United Kingdom.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Jun 09; Vol. 13, pp. 903755. Date of Electronic Publication: 2022 Jun 09 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibody-Dependent Cell Cytotoxicity*
Immunoglobulin G*
Animals ; Antibodies, Monoclonal ; Antigen-Antibody Complex ; Complement System Proteins ; Phagocytosis ; Swine
Czasopismo naukowe
Tytuł:
Ultrasensitive antibody production strategy based on hapten property for simultaneous immunoassay.
Autorzy:
Wu W; College of Science, China Agricultural University, Beijing 100193, China.
Li C; College of Science, China Agricultural University, Beijing 100193, China.
Liu D; College of Science, China Agricultural University, Beijing 100193, China.
Ji J; College of Science, China Agricultural University, Beijing 100193, China.
Zhu J; College of Science, China Agricultural University, Beijing 100193, China.
Lu H; College of Science, China Agricultural University, Beijing 100193, China.
Fu B; College of Science, China Agricultural University, Beijing 100193, China. Electronic address: .
Ma Y; College of Science, China Agricultural University, Beijing 100193, China.
Pokaż więcej
Źródło:
Food chemistry [Food Chem] 2022 Nov 30; Vol. 395, pp. 133565. Date of Electronic Publication: 2022 Jun 23.
Typ publikacji:
Journal Article
MeSH Terms:
Antibody Formation*
Haptens*/chemistry
Antibodies ; Antibody Specificity ; Enzyme-Linked Immunosorbent Assay ; Immunoassay ; Models, Molecular
Czasopismo naukowe
Tytuł:
In silico proof of principle of machine learning-based antibody design at unconstrained scale.
Autorzy:
Akbar R; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Robert PA; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Weber CR; Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
Widrich M; Ellis Unit Linz and Lit Ai Lab, Institute for Machine Learning, Johannes Kepler University Linz, Linz, Austria.
Frank R; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Pavlović M; Department of Informatics, University of Oslo, Oslo, Norway.
Scheffer L; Department of Informatics, University of Oslo, Oslo, Norway.
Chernigovskaya M; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Snapkov I; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Slabodkin A; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Mehta BB; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Miho E; Institute of Medical Engineering and Medical Informatics, School of Life Sciences, FHNW University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland.
Lund-Johansen F; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Andersen JT; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.; Institute of Clinical Medicine, Department of Pharmacology, University of Oslo, Oslo, Norway.
Hochreiter S; Ellis Unit Linz and Lit Ai Lab, Institute for Machine Learning, Johannes Kepler University Linz, Linz, Austria.; Institute of Advanced Research in Artificial Intelligence (IARAI), Austria.
Hobæk Haff I; Department of Mathematics, University of Oslo, Oslo, Norway.
Klambauer G; Ellis Unit Linz and Lit Ai Lab, Institute for Machine Learning, Johannes Kepler University Linz, Linz, Austria.
Sandve GK; Department of Informatics, University of Oslo, Oslo, Norway.
Greiff V; Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, Norway.
Pokaż więcej
Źródło:
MAbs [MAbs] 2022 Jan-Dec; Vol. 14 (1), pp. 2031482.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigen-Antibody Reactions*
Machine Learning*
Antibodies, Monoclonal/chemistry ; Binding Sites, Antibody ; Epitopes
Czasopismo naukowe
Tytuł:
Laboratory Diagnosis of ANCA-Associated Vasculitis (AAV) Using a Combination of Immunofluorescence Test (IIFT) and Line Immunoassay (LIA): Single-Centre Report From India.
Autorzy:
Chauhan R; Molecular and Transplant Immunology Laboratory, Department of Transfusion Medicine, Medanta-The Medicity, Gurgaon, India; Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, India.
Jain D; Molecular and Transplant Immunology Laboratory, Department of Transfusion Medicine, Medanta-The Medicity, Gurgaon, India.
Tiwari AK; Molecular and Transplant Immunology Laboratory, Department of Transfusion Medicine, Medanta-The Medicity, Gurgaon, India.
Dorwal P; Molecular and Transplant Immunology Laboratory, Department of Transfusion Medicine, Medanta-The Medicity, Gurgaon, India.
Raina V; Chimera Transplant Research Foundation, New Delhi, India.
Nandi SP; Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, India. Electronic address: .
Pokaż więcej
Źródło:
Reumatologia clinica [Reumatol Clin (Engl Ed)] 2022 Jan; Vol. 18 (1), pp. 15-19.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/diagnosis
Churg-Strauss Syndrome*
Granulomatosis with Polyangiitis*/diagnosis
Clinical Laboratory Techniques ; Fluorescent Antibody Technique ; Humans ; Immunoassay
Czasopismo naukowe
Tytuł:
Fc-engineered antibodies with immune effector functions completely abolished.
Autorzy:
Wilkinson I; Absolute Antibody Ltd, Wilton, United Kingdom.; mAbsolve Limited, Oxford, United Kingdom.
Anderson S; Absolute Antibody Ltd, Wilton, United Kingdom.
Fry J; ProImmune Limited, Oxford, United Kingdom.
Julien LA; Antibody Analytics Limited, Motherwell, Scotland.
Neville D; Reading Scientific Services Limited, Reading, United Kingdom.
Qureshi O; Celentyx Limited, Birmingham, United Kingdom.
Watts G; Abzena Limited, Babraham, United Kingdom.
Hale G; mAbsolve Limited, Oxford, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Dec 21; Vol. 16 (12), pp. e0260954. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibody-Dependent Cell Cytotoxicity*
Complement C1q/*metabolism
Histocompatibility Antigens Class I/*metabolism
Immunoglobulin Fc Fragments/*metabolism
Immunoglobulin G/*metabolism
Receptors, Fc/*metabolism
Receptors, IgG/*metabolism
Amino Acid Substitution ; Antibody Affinity ; Complement C1q/genetics ; Complement C1q/immunology ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Humans ; Immunoglobulin Fc Fragments/genetics ; Immunoglobulin Fc Fragments/immunology ; Immunoglobulin G/genetics ; Immunoglobulin G/immunology ; Protein Binding ; Protein Engineering ; Receptors, Fc/genetics ; Receptors, Fc/immunology ; Receptors, IgG/genetics ; Receptors, IgG/immunology
Czasopismo naukowe
Tytuł:
A single homogeneous assay for simultaneous measurement of bispecific antibody target binding.
Autorzy:
Christian EA; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Electronic address: .
Hussmann GP; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Babu M; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Prophet M; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Mazor Y; Department of Antibody Discovery and Protein Engineering, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Chen W; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Grigoriadou C; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Lin S; Department of Analytical Sciences, BioPharmaceuticals Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Pokaż więcej
Źródło:
Journal of immunological methods [J Immunol Methods] 2021 Sep; Vol. 496, pp. 113099. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji:
Journal Article
MeSH Terms:
Antibody Specificity*
Immunoassay*
Antibodies, Bispecific/*immunology
Antigens/*immunology
CTLA-4 Antigen/*immunology
Programmed Cell Death 1 Receptor/*immunology
Antibodies, Bispecific/metabolism ; Antigen-Antibody Complex ; Antigens/metabolism ; Binding Sites, Antibody ; Buffers ; CTLA-4 Antigen/metabolism ; Enzyme-Linked Immunosorbent Assay ; Epitopes ; Humans ; Hydrogen-Ion Concentration ; Kinetics ; Predictive Value of Tests ; Programmed Cell Death 1 Receptor/metabolism ; Protein Binding ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection.
Autorzy:
Wegman AD; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY, United States.
Fang H; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY, United States.
Rothman AL; Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States.
Thomas SJ; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY, United States.; Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, NY, United States.
Endy TP; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY, United States.
McCracken MK; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.
Currier JR; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.
Friberg H; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.
Gromowski GD; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.
Waickman AT; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY, United States.; Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, NY, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2021 Nov 24; Vol. 12, pp. 777672. Date of Electronic Publication: 2021 Nov 24 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Antibody-Dependent Enhancement*
Opsonization*
Antibodies, Monoclonal/*immunology
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Dengue/*immunology
Dengue Virus/*immunology
Immunoglobulin A/*immunology
Immunoglobulin G/*immunology
Animals ; Antibodies, Monoclonal/metabolism ; Antibodies, Neutralizing/metabolism ; Antibodies, Viral/metabolism ; Antibody Specificity ; Chlorocebus aethiops ; Dengue/metabolism ; Dengue/virology ; Dengue Virus/metabolism ; Dengue Virus/pathogenicity ; Host-Pathogen Interactions ; Humans ; Immunity, Humoral ; Immunoglobulin A/metabolism ; Immunoglobulin Class Switching ; Immunoglobulin G/metabolism ; K562 Cells ; Vero Cells
Czasopismo naukowe
Tytuł:
Strong Association of the Myriad Discrete Speckled Nuclear Pattern With Anti-SS-A/Ro60 Antibodies: Consensus Experience of Four International Expert Centers.
Autorzy:
Röber N; Institute of Immunology, Technical University Dresden, Dresden, Germany.
Dellavance A; Division of Research and Development, Fleury Medicine and Health Laboratories, São Paulo, Brazil.
Ingénito F; Immunology Laboratory, Durand Hospital, Buenos Aires, Argentina.
Reimer ML; Institute of Immunology, Technical University Dresden, Dresden, Germany.
Carballo OG; Immunology Laboratory, Durand Hospital, Buenos Aires, Argentina.
Conrad K; Institute of Immunology, Technical University Dresden, Dresden, Germany.
Chan EKL; Department of Oral Biology, University of Florida, Gainesville, FL, United States.
Andrade LEC; Division of Immunology, Fleury Medicine and Health Laboratories, São Paulo, Brazil.; Division of Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2021 Oct 05; Vol. 12, pp. 730102. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Fluorescent Antibody Technique, Indirect*
Antibodies, Antinuclear/*analysis
Autoantigens/*immunology
Autoimmune Diseases/*diagnosis
Cell Nucleus/*immunology
RNA, Small Cytoplasmic/*immunology
Ribonucleoproteins/*immunology
Antibodies, Monoclonal/immunology ; Antibody Specificity ; Argentina ; Autoimmune Diseases/immunology ; Brazil ; Cell Line ; Consensus ; Florida ; Germany ; Humans ; Observer Variation ; Predictive Value of Tests ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.
Autorzy:
Gallichotte EN; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Nehring M; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Young MC; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Pugh S; Department of Statistics, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Sexton NR; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Fitzmeyer E; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Quicke KM; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Richardson M; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Pabilonia KL; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Ehrhart N; Columbine Health Systems Center for Healthy Aging and Department of Clinical Sciences, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Fosdick BK; Department of Statistics, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
VandeWoude S; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Ebel GD; Department of Microbiology, Immunology and Pathology, Colorado State Universitygrid.47894.36, Fort Collins, Colorado, USA.
Pokaż więcej
Źródło:
Microbiology spectrum [Microbiol Spectr] 2021 Sep 03; Vol. 9 (1), pp. e0022421. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibody Formation*
Disease Outbreaks*
Long-Term Care*
COVID-19/*epidemiology
COVID-19/*immunology
Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Asymptomatic Infections/epidemiology ; Binding Sites, Antibody ; COVID-19 Testing ; Humans ; Immunologic Surveillance ; RNA, Viral ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Sensitivity and Specificity ; Seroepidemiologic Studies ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe
Tytuł:
Selection and identification of single-domain antibody against Peste des Petits Ruminants virus.
Autorzy:
Liu D; Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
Li L; Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
Cao X; Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
Wu J; Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China. .
Du G; Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
Shang Y; Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
Pokaż więcej
Źródło:
Journal of veterinary science [J Vet Sci] 2021 Jul; Vol. 22 (4), pp. e45. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji:
Journal Article
MeSH Terms:
Antibody Specificity*
Camelus*
Viral Vaccines*
Antibodies, Viral/*immunology
Peste-des-Petits-Ruminants/*prevention & control
Peste-des-petits-ruminants virus/*immunology
Animals ; Antibody Affinity ; Chlorocebus aethiops ; Cloning, Molecular ; Female ; Gene Library ; RNA, Messenger ; Vero Cells
Czasopismo naukowe
Tytuł:
A Prevalent Focused Human Antibody Response to the Influenza Virus Hemagglutinin Head Interface.
Autorzy:
McCarthy KR; Laboratory of Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Lee J; Thayer School of Engineering, Dartmouth College, Hannover, New Hampshire, USA.
Watanabe A; Department of Immunology, Duke University, Durham, North Carolina, USA.
Kuraoka M; Department of Immunology, Duke University, Durham, North Carolina, USA.
Robinson-McCarthy LR; Harvard Medical School, Boston, Massachusetts, USA.
Georgiou G; Department of Chemical Engineering, University of Texas at Austin, Austin, Texas, USA.; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.; Department of Biomedical Engineering, University of Texas at Austin, Austin, Texas, USA.; Department of Oncology, University of Texas at Austin, Austin, Texas, USA.
Kelsoe G; Department of Immunology, Duke University, Durham, North Carolina, USA.
Harrison SC; Laboratory of Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Howard Hughes Medical Institute, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2021 Jun 29; Vol. 12 (3), pp. e0114421. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Antibody Formation*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Hemagglutinin Glycoproteins, Influenza Virus/*genetics
Hemagglutinin Glycoproteins, Influenza Virus/*immunology
Influenza, Human/*immunology
Animals ; Antibodies, Neutralizing/metabolism ; Antibodies, Viral/metabolism ; Binding Sites, Antibody ; Cell Line ; Hemagglutination Inhibition Tests ; Hemagglutinin Glycoproteins, Influenza Virus/chemistry ; Hemagglutinin Glycoproteins, Influenza Virus/metabolism ; Humans ; Mice ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/virology ; Prevalence
Czasopismo naukowe
Tytuł:
Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies.
Autorzy:
Raleigh MD; Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States of America.; Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Beltraminelli N; Blink Biomedical, Marseille, France.
Fallot S; Blink Biomedical, Marseille, France.
LeSage MG; Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States of America.; Nic•mAb Strategic Alliance, San Diego, California, United States of America.
Saykao A; Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States of America.
Pentel PR; Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States of America.; Nic•mAb Strategic Alliance, San Diego, California, United States of America.
Fuller S; Nic•mAb Strategic Alliance, San Diego, California, United States of America.; Antidote Therapeutics, Inc., Woodbine, Maryland, United States of America.
Thisted T; Nic•mAb Strategic Alliance, San Diego, California, United States of America.; Antidote Therapeutics, Inc., Woodbine, Maryland, United States of America.
Biesova Z; Antidote Therapeutics, Inc., Woodbine, Maryland, United States of America.
Horrigan S; Noble Life Sciences, Woodbine, Maryland, United States of America.
Sampey D; Nic•mAb Strategic Alliance, San Diego, California, United States of America.; Biofactura, Inc., Frederick, Maryland, United States of America.
Zhou B; Nic•mAb Strategic Alliance, San Diego, California, United States of America.; The Scripps Research Institute, La Jolla, California, United States of America.
Kalnik MW; Nic•mAb Strategic Alliance, San Diego, California, United States of America.; Antidote Therapeutics, Inc., Woodbine, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 30; Vol. 16 (7), pp. e0254247. Date of Electronic Publication: 2021 Jul 30 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antibodies, Monoclonal*/chemistry
Antibodies, Monoclonal*/pharmacokinetics
Antibodies, Monoclonal*/pharmacology
Antibody Affinity*
Nicotine*/chemistry
Nicotine*/pharmacokinetics
Tobacco Use Disorder*/drug therapy
Tobacco Use Disorder*/metabolism
Brain/*metabolism
Animals ; Antigen-Antibody Complex/chemistry ; Humans ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł:
Beyond Binding: The Outcomes of Antibody-Dependent Complement Activation in Human Malaria.
Autorzy:
Rathnayake D; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Aitken EH; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Rogerson SJ; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2021 Jun 08; Vol. 12, pp. 683404. Date of Electronic Publication: 2021 Jun 08 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Antibody-Dependent Cell Cytotoxicity*
Antibodies, Protozoan/*immunology
Complement Activation/*immunology
Complement System Proteins/*immunology
Host-Parasite Interactions/*immunology
Malaria/*immunology
Plasmodium/*immunology
Antigen-Antibody Complex/immunology ; Complement Pathway, Classical/immunology ; Erythrocytes/immunology ; Erythrocytes/parasitology ; Humans ; Life Cycle Stages ; Malaria/parasitology ; Plasmodium/growth & development
Czasopismo naukowe
Tytuł:
Bacterial coloration immunofluorescence strip for ultrasensitive rapid detection of bacterial antibodies and targeted antibody-secreting hybridomas.
Autorzy:
Fang S; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China; College of Food and Bioengineering, Bengbu University, Bengbu 233030, China.
Yang H; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Liu C; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Tian Y; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Wu M; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Wu Y; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Liu Q; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China; Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266071, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of immunological methods [J Immunol Methods] 2022 Feb; Vol. 501, pp. 113208. Date of Electronic Publication: 2021 Dec 20.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Enzyme-Linked Immunosorbent Assay*
Reagent Strips*
Antibodies, Bacterial/*analysis
Escherichia coli/*immunology
Escherichia coli Infections/*diagnosis
Fluorescent Antibody Technique/*instrumentation
Vibrio Infections/*diagnosis
Vibrio parahaemolyticus/*immunology
Yersinia enterocolitica/*immunology
Animals ; Antibody Specificity ; Antigens, Bacterial/immunology ; Bacterial Load ; Escherichia coli Infections/immunology ; Escherichia coli Infections/microbiology ; Hybridomas ; Mice, Inbred BALB C ; Predictive Value of Tests ; Reproducibility of Results ; Vibrio Infections/immunology ; Vibrio Infections/microbiology ; Workflow
Czasopismo naukowe
Tytuł:
Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target.
Autorzy:
Kroenke MA; Clinical Immunology, Translational Medicine, Amgen, Thousand Oaks, CA, United States.
Barger TE; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States.
Hu J; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States.
Miller MJ; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States.
Kalenian K; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States.
He L; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States.
Hsu H; Inflammation Research, Amgen, Thousand Oaks, CA, United States.
Bartley Y; Global Safety, Amgen, Thousand Oaks, CA, United States.
Chow VF; Clinical Pharmacology, Modeling and Simulation, Translational Medicine, Amgen, Thousand Oaks, CA, United States.
Teixeira Dos Santos MC; Clinical Biomarkers and Diagnostics, Translational Medicine, Amgen, Thousand Oaks, CA, United States.
Sullivan BA; Clinical Biomarkers and Diagnostics, Translational Medicine, Amgen, Thousand Oaks, CA, United States.
Cheng LE; Early Development, Translational Medicine, Amgen, Thousand Oaks, CA, United States.
Parnes JR; Early Development, Translational Medicine, Amgen, Thousand Oaks, CA, United States.
Padaki R; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States.
Kuhns S; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States.
Mytych DT; Clinical Immunology, Translational Medicine, Amgen, Thousand Oaks, CA, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2021 Dec 14; Vol. 12, pp. 782788. Date of Electronic Publication: 2021 Dec 14 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibody Formation*
Immune Tolerance*
Antibodies, Bispecific/*adverse effects
Antigen-Antibody Complex/*immunology
Drug-Related Side Effects and Adverse Reactions/*diagnosis
Drug-Related Side Effects and Adverse Reactions/*etiology
Antibodies, Bispecific/immunology ; Antibodies, Bispecific/pharmacokinetics ; Antibodies, Bispecific/therapeutic use ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Biomarkers/blood ; Drug-Related Side Effects and Adverse Reactions/blood ; HLA Antigens/genetics ; HLA Antigens/immunology ; Humans ; Immunoassay ; Isoantibodies/immunology ; Protein Binding/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism
Czasopismo naukowe
Tytuł:
Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice.
Autorzy:
Chang TC; Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
Chen BM; Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
Wu JY; Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan; School of Chinese Medicine, China Medical University, Taichung 40447, Taiwan.
Cheng TL; Department of Biomedical Science and Environmental Biology, Center for Biomarkers and Biotech Drugs, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Roffler S; Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Feb; Vol. 146, pp. 112502. Date of Electronic Publication: 2021 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Antibody Affinity/*immunology
Erythropoietin/*immunology
Erythropoietin/*pharmacokinetics
Immunoglobulin G/*immunology
Immunoglobulin M/*immunology
Polyethylene Glycols/*pharmacokinetics
Animals ; Antigen-Antibody Complex/immunology ; Cell Line ; Clustered Regularly Interspaced Short Palindromic Repeats ; Female ; Gene Editing ; Metabolic Clearance Rate ; Mice ; Mice, Inbred BALB C ; Recombinant Proteins/immunology ; Recombinant Proteins/pharmacokinetics
Czasopismo naukowe
Tytuł:
Identification of critical chemical modifications and paratope mapping by size exclusion chromatography of stressed antibody-target complexes.
Autorzy:
Bondarenko P; Attribute Sciences, Process Development, Amgen Inc , Thousand Oaks, CA, USA.
Nichols AC; Attribute Sciences, Process Development, Amgen Inc , Thousand Oaks, CA, USA.
Xiao G; Attribute Sciences, Process Development, Amgen Inc , Thousand Oaks, CA, USA.
Shi RL; Attribute Sciences, Process Development, Amgen Inc , Thousand Oaks, CA, USA.
Chan PK; Attribute Sciences, Process Development, Amgen Inc , Thousand Oaks, CA, USA.
Dillon TM; Attribute Sciences, Process Development, Amgen Inc , Thousand Oaks, CA, USA.
Garces F; Department of Therapeutics Discovery, Amgen Research, Amgen Inc , Thousand Oaks, CA, USA.
Semin DJ; Attribute Sciences, Process Development, Amgen Inc , Thousand Oaks, CA, USA.
Ricci MS; Attribute Sciences, Process Development, Amgen Inc , Thousand Oaks, CA, USA.
Pokaż więcej
Źródło:
MAbs [MAbs] 2021 Jan-Dec; Vol. 13 (1), pp. 1887629.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigen-Antibody Complex*
Chromatography, Gel*
Epitope Mapping*
Epitopes*
Antibodies, Monoclonal/*metabolism
Antigens/*metabolism
Immunoglobulin G/*metabolism
Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Antibody Specificity ; Antigen-Antibody Reactions ; Antigens/immunology ; Binding Sites, Antibody ; Immunoglobulin G/chemistry ; Immunoglobulin G/immunology ; Peptide Mapping ; Protein Stability ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł:
Immune checkpoint inhibitors as potential triggers for ANCA vasculitis.
Autorzy:
Aqeel F; Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA .
Monroy-Trujillo J; Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Geetha D; Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
RMD open [RMD Open] 2022 Aug; Vol. 8 (2).
Typ publikacji:
Letter
MeSH Terms:
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/drug therapy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/etiology
Antibodies, Antineutrophil Cytoplasmic*/therapeutic use
Humans ; Immune Checkpoint Inhibitors/adverse effects ; Rituximab/therapeutic use
Opinia redakcyjna
Tytuł:
Distinct Antibody Responses to Endemic Coronaviruses Pre- and Post-SARS-CoV-2 Infection in Kenyan Infants and Mothers.
Autorzy:
Stoddard CI; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Sung K; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Ojee E; Department of Pediatrics and Child Health, University of Nairobi, Nairobi 00100, Kenya.
Adhiambo J; Department of Pediatrics and Child Health, University of Nairobi, Nairobi 00100, Kenya.
Begnel ER; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Slyker J; Department of Global Health, University of Washington, Seattle, WA 98195, USA.; Department of Epidemiology, University of Washington, Seattle, WA 98195, USA.
Gantt S; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC H3T 1J4, Canada.; Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC H3T 1C5, Canada.
Matsen FA 4th; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Kinuthia J; Department of Global Health, University of Washington, Seattle, WA 98195, USA.; Department of Research and Programs, Kenyatta National Hospital, Nairobi 00202, Kenya.
Wamalwa D; Department of Pediatrics and Child Health, University of Nairobi, Nairobi 00100, Kenya.
Overbaugh J; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Lehman DA; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Jul 12; Vol. 14 (7). Date of Electronic Publication: 2022 Jul 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibody Formation*
COVID-19*/epidemiology
Coronavirus 229E, Human*
Coronavirus Infections*/immunology
Coronavirus OC43, Human*
Antibodies, Viral ; Cross Reactions ; Female ; Humans ; Infant ; Kenya/epidemiology ; SARS-CoV-2
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz